Nature's Way AM Formula product packaging

Image: NIH Office of Dietary Supplements, Dietary Supplement Label DatabaseNo separate image reuse license stated

Nature's Way

AM Formula

Tablet or Pill

Serving size1 Tablet(s)
Servings per containerNot listed
Package30 AM Tablet(s)
Data retrievedJul 28, 2026

Checking your goal…

Checking with your list…

1 labeled serving/day preview
Open the complete check →

Supplement Facts

Serving size 1 Tablet(s)

Sunphenon250 mgDV not established
Caffeine50 mgDV not established
Asian Ginseng Root Extract100 mgDV not established
Ginsenosides7 mgDV not established
Black Cohosh Rhizome; Root Extract20 mgDV not established
Triterpene Glycosides0.5 mgDV not established

Other ingredients

Cellulose; Sodium Croscarmellose; Stearic Acid (C18:0); Hypromellose; Magnesium Stearate (Mg Stearate); Silica; Glycerin

Label directions

Recommendation: AM: Women take 1 (tan) AM tablet in the morning.It may take four to five weeks to achieve full benefits. Continue use to maintain benefits. Do not take other Cimicifuga (black cohosh) containing products concurrently.

Label warnings

Keep out of reach of children. This product has a tamper-evident foil pouch. Do not use if foil or plastic is punctured. Do not take other Cimicifuga (black cohosh) containing products concurrently. Warning for AM Tablet: Do not use if you are pregnant nursing under 18 years of age or sensitive to caffeine. If you have diabetes or if you are taking any medications consult a healthcare professional before use. Warning for AM Tablet: Do not use if you are pregnant nursing under 18 years of age or sensitive to caffeine. Each serving of this product contains 50 mg of caffeine. Discontinue use and consult a healthcare professional if you have a liver disorder or develop symptoms of liver trouble such as abdominal pain dark urine or jaundice.

Identity and label version

NIH label record333900
Entered into NIH DSLDAug 22, 2025
UPC / GTIN00763948072064
Manufacturer / distributor on labelNature's Way Brands LLC
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.

NIH label history (2)

Current labelNIH record 333900Entered Aug 22, 2025
Serving size1 Tablet(s)
Formula version64366c8f
Ingredients on label6
NIH sourceOpen label ↗
Sunphenon250 mg
Caffeine50 mg
Asian Ginseng Root Extract100 mg
Ginsenosides7 mg
Black Cohosh Rhizome; Root Extract20 mg
Triterpene Glycosides0.5 mg

Label warning: Keep out of reach of children. This product has a tamper-evident foil pouch. Do not use if foil or plastic is punctured. Do not take other Cimicifuga (black cohosh) containing products concurrently. Warning for AM Tablet: Do not use if you are pregnant nursing under 18 years of age or sensitive to caffeine. If you have diabetes or if you are taking any medications consult a healthcare professional before use. Warning for AM Tablet: Do not use if you are pregnant nursing under 18 years of age or sensitive to caffeine. Each serving of this product contains 50 mg of caffeine. Discontinue use and consult a healthcare professional if you have a liver disorder or develop symptoms of liver trouble such as abdominal pain dark urine or jaundice.

Earlier labelNIH record 333901Entered Jul 24, 2025
Serving size1 Tablet(s)
Formula versionf0d82c6f
Ingredients on label7
NIH sourceOpen label ↗
Total Carbohydrates<1 g
Valerian Root Extract200 mg
Valerenic Acid1.6 mg
Hops Flower Extract100 mg
Suntheanine50 mg
Black Cohosh Rhizome; Root Extract20 mg
Triterpene Glycosides0.5 mg

Label warning: Keep out of reach of children. This product has a tamper-evident foil pouch. Do not use if foil or plastic is punctured. Do not take other Cimicifuga (black cohosh) containing products concurrently. Warning for PM tablet: Do not take if you are pregnant or nursing. If you are taking sedatives tranquilizers or any other medications consult a healthcare professional before use. Avoid alcohol and do not drive or operate machinery while taking this product as it may cause drowsiness. Discontinue use and consult a healthcare professional if you have a liver disorder or develop symptoms of liver trouble such as abdominal pain dark urine or jaundice.

Sources and traceability

  • NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026
    Open source ↗

More from Nature's Way

Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.